Barnett Brian Gill 4

4 · OncBioMune Pharmaceuticals, Inc · Filed Apr 30, 2019

Insider Transaction Report

Form 4
Period: 2019-04-24
Barnett Brian Gill
Chief Executive Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-04-24+8,347,2458,347,245 total
    Exercise: $0.01From: 2020-01-09Exp: 2029-04-24Common Stock (8,347,245 underlying)
Footnotes (3)
  • [F1]This terms of this grant were included in the reporting person's employment agreement entered into on December 24, 2018 but the grant was not effective until April 24, 2019.
  • [F2]One-third of the Stock Options vest on January 9, 2020, January 9, 2021 and January 9, 2022.
  • [F3]Options issued as compensation approved by the Issuer's Board of Directors.

Documents

1 file
  • 4
    ownership.xmlPrimary